Ex Parte PORTUGAL et al - Page 5



              Appeal No. 2004-1967                                                                Page 5                
              Application No. 09/027,439                                                                                
                     hybridization at 40°-65°C for 14-16 hours in a hybridization solution at pH 7.8,                   
              containing 0.9 M NaCl, 0.12 M Tris-HCl, 6 nM EDTA, 0.1 M sodium phosphate buffer,                         
              0.1% SDS and 0.1% polyvinylpyrrolidone,                                                                   
                     followed by three 15-minute washes at 40°-65°C to remove unbound probes in a                       
              solution at pH 7, containing 0.075 M NaCl, 0.0075 M Na Citrate and 0.1% SDS.                              
                     53. An isolated nucleic acid molecule comprising a nucleotide sequence of SEQ                      
              ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, or SEQ ID NO: 6,                                                    
                     or an RNA equivalent thereof,                                                                      
                     or a nucleic acid complementary to said isolated molecule, capable of base-                        
              pairing according to standard Watson-Crick complementarity rules.                                         
                     The claims stand rejected as follows:                                                              
                     I.  Claims 55-58 under 35 U.S.C. § 112, second paragraph, as indefinite.                           
                     II.  Claims 55-58 under 35 U.S.C. § 101 as “directed to non-statutory subject                      
              matter.                                                                                                   
                     III.  Claims 47, 48, 53 and 55-58 under 35 U.S.C. § 102(a) and (e) as anticipated                  
              by Hogan.2                                                                                                
                     IV. Claims 47, 48, 53 and 55-58 under 35 U.S.C. § 102(a) as anticipated by                         
              Genbank Accession No. X969643 or X807264 (disclosed in Cilia5).                                           
                     V. Claims 47, 48, 53 and 55-58 under 35 U.S.C. § 103 as unpatentable over                          
              Genbank Accession No. A145656 and Dyson.7                                                                 


                     2 Hogan et al., U.S. Patent 5,541,308, issued July 30, 1996.                                       
                     3 Genbank Accession No. X96964, February 4, 1996.                                                  
                     4 Genbank Accession No. X80726, March 29, 1996.                                                    
                     5 Cilia et al., “Sequence Heterogeneities Among 16S Ribosomal RNA                                  
              Sequences, and Their Effect on Phylogenetic Analyses at the Species Level,” Mol. Biol.                    
              Evol., Vol. 13, No. 3, pp. 451-461 (February 20, 1996).                                                   
                     6 Genbank Accession No. A14565, September 29, 1994.                                                
                     7 Dyson, N.J., in Essential Molecular Biology Vol. II: A Practical Approach,                       
              Chapter 5, pp. 11-156, Brown, T.A. ed., Oxford University Press, 1992.                                    






Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007